Molecular predictors of response to venetoclax plus hypomethylating agent in treatment-naïve acute myeloid leukemia.

Authors :: Gangat N
Johnson I
McCullough K
Farrukh F
Al-Kali A
Alkhateeb H
Begna K
Mangaonkar A
Litzow M
Hogan W
Shah M
Patnaik M
Pardanani A
Tefferi A
Source :: Haematologica [Haematologica] 2022 Oct 01; Vol. 107 (10), pp. 2501-2505. Date of Electronic Publication: 2022 Oct 01.
Publication Year :: 2022

Subjects :: Antineoplastic Combined Chemotherapy Protocols adverse effects
Humans
Sulfonamides therapeutic use
Bridged Bicyclo Compounds, Heterocyclic therapeutic use
Leukemia, Myeloid, Acute diagnosis
Leukemia, Myeloid, Acute drug therapy
Leukemia, Myeloid, Acute genetics

Full Text Access

Tools